Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

The Clinical Impact of Modified Barthel Index in Elderly Patients over 60 Years with Diffuse Large B-Cell Lymphoma

Shinji Ogura, MD, Masahiro Akimoto, Aki Sakurai, MD, Chisako Ito, Yuriko Fujita, Yoshinobu Aisa, Tomonori Nakazato, MD PhD

Blood (2019) 134 (Supplement_1): 4119.

https://doi.org/10.1182/blood-2019-125573

Published: 2019

Journal Articles

Comparison of the Clinical Outcomes of Nilotinib and Dasatinib Therapies in Newly Diagnosed Patients in the Chronic Phase of Chronic Myeloid Leukemia: A Retrospective Analysis

Noriyoshi Iriyama, MD PhD, Kei-Ji Sugimoto, Eriko Sato, MD PhD, Tomoiku Takaku, MD PhD, Michihide Tokuhira, Tomonori Nakazato, MD PhD, Maho Ishikawa, MD, Hiroyuki Fujita, MD PhD, Yuta Kimura, MD, Isao Fujioka, MD, Norio Asou, MD PhD, Masahiro Kizaki, MD PhD, Norio Komatsu, MD PhD, Yoshihiro Hatta, MD PhD, Tatsuya Kawaguchi, MD PhD

Blood (2018) 132 (Supplement 1): 4268.

https://doi.org/10.1182/blood-2018-99-111732

Published: 2018

Journal Articles

Serum Reactive Oxygen Metabolite Levels Are Associated with Poor Prognosis in Patients with Diffuse Large B-Cell Lymphoma

Shinji Ogura, Takahiro Kamiya, Kota Mizuno, Chisako Ito, Yuriko Fujita, Yoshinobu Aisa, Tomonori Nakazato, MD PhD

Blood (2018) 132 (Supplement 1): 1704.

https://doi.org/10.1182/blood-2018-99-111874

Published: 2018

Journal Articles

Prognostic Significance of Neuron-Specific Enolase in Patients with Malignant Lymphoma

Kota Mizuno, Shinji Ogura, Takahiro Kamiya, Chisako Ito, Yuriko Fujita, Yoshinobu Aisa, Tomonori Nakazato, MD PhD

Blood (2018) 132 (Supplement 1): 1708.

https://doi.org/10.1182/blood-2018-99-113986

Published: 2018

Journal Articles

A Prospective Observational Study Evaluating Sarcopenia By Using the Bioelectrical Impedance Analysis in Elderly Patients with Hematologic Malignancies

Takahiro Kamiya, Kota Mizuno, Shinji Ogura, Chisako Ito, Yuriko Fujita, Yoshinobu Aisa, Tomonori Nakazato, MD PhD

Blood (2018) 132 (Supplement 1): 4851.

https://doi.org/10.1182/blood-2018-99-114545

Published: 2018

Journal Articles

Phase II Clinical Trial of Personalized-VCD-VTD Sequential Therapy Using VES-13 for Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma

Tomonori Nakazato, MD PhD, Masao Hagihara, Seiji Irie, Naohi Sahara, Eri Tanaka, Yotaro Tamai, Ryuji Ishii, Shigehisa Tamaki, Atsushi Wake, MD PhD, Kenji Tajika, Rika Sakai, MD PhD, Takeshi Kobayashi, MD, Fumiya Sano, Takayuki Abe, Rachel Roberts, Shin Fujisawa, MD PhD, Koji Miyazaki, Masaaki Higashihara

Blood (2017) 130 (Supplement 1): 3162.

https://doi.org/10.1182/blood.V130.Suppl_1.3162.3162

Published: 2017

Journal Articles

Successful MPB Therapy Followed By Bortezomib Maintenance for Non-Transplant Eligible Patients with Newly Diagnosed Multiple Myeloma: Japanese Phase 2 Study - Broad-J Study

Blood (2017) 130 (Supplement 1): 5432.

https://doi.org/10.1182/blood.V130.Suppl_1.5432.5432

Published: 2017

Journal Articles

Oxidative Stress Is Associated with Poor Prognosis in Patients with Malignant Lymphoma

Tomonori Nakazato, MD PhD, Chisako Ito, Yoshinobu Aisa

Blood (2014) 124 (21): 1653.

https://doi.org/10.1182/blood.V124.21.1653.1653

Published: 2014

Journal Articles

Once-Weekly Subcutaneous Bortezomib Plus Oral Cyclophosphamide and Dexamethasone Therapy For Relapsed Or Refractory Multiple Myeloma

Yasushi Takamatsu, MD, PhD, Yutaka Imamura, MD, Tomonori Nakazato, MD, Naokuni Uike, MD, PhD, Kaname Miyashita, MD, Yoshio Saburi, MD, PhD, Naoki Harada, MD, Shuichi Ota, MD, PhD, Rie Imamura, MD, Toshihiro Miyamoto, MD

Blood (2013) 122 (21): 5382.

https://doi.org/10.1182/blood.V122.21.5382.5382

Published: 2013

Journal Articles

Myeloperoxidase (MPO) Is a Key Regulator of Oxidative Stress-Mediated Apoptosis in Myeloid Leukemic Cells.

Masahiro Kizaki, MD, Tomonori Nakazato, MD, Morihiko Sagawa, MD, Kenji Yamato, MD, Mingji Xian, MD, Yasuo Ikeda, MD

Blood (2006) 108 (11): 1923.

https://doi.org/10.1182/blood.V108.11.1923.1923

Published: 2006

Journal Articles

Green Tea Component, Catechin, Induces Apoptosis of Myeloid Leukemic Cells Via Myeloperoxidase (MPO)-Dependent Highly Reactive Oxygen Species (ROS) Production.

Tomonori Nakazato, MD, Kenji Yamato, MD, Morihiko Sagawa, MD, Yuriko Nishiyama, MD, Yasuo Ikeda, MD, Masahiro Kizaki, MD

Blood (2005) 106 (11): 4429.

https://doi.org/10.1182/blood.V106.11.4429.4429

Published: 2005

Journal Articles

Shikonin Induces Apoptosis by Inhibiting Phosphorylation of IGF-1 Receptor in Myeloma Cells.

Takehiro Kimura, MD, Tomonori Nakazato, MD, Takatsune Shimizu, MD, Yasuo Ikeda, MD, Masahiro Kizaki, MD

Blood (2004) 104 (11): 4858.

https://doi.org/10.1182/blood.V104.11.4858.4858

Published: 2004

Journal Articles

A Green Tea Component, Catechin, Induces Apoptosis of Human Myeloma Cells and Markedly Enhances Arsenic Trioxide-Induced Cytotoxicity Via Production of Reactive Oxygen Species (ROS).

Tomonori Nakazato, MD, Keisuke Ito, MD, Yoshitaka Miyakawa, MD, Yasuo Ikeda, MD, Masahiro Kizaki, MD

Blood (2004) 104 (11): 2475.

https://doi.org/10.1182/blood.V104.11.2475.2475

Published: 2004

Journal Articles

1′-Acetoxychavicol Acetate (ACA) Is a Novel NF-κB Inhibitor with Significant Activity Against Multiple Myeloma in Vitro and in Vivo .

Keisuke Ito, MD, Tomonori Nakazato, MD, Yoshitaka Miyakawa, MD, Ming Ji Xian, MD, Taketo Yamada, MD, Hajime Ohigashi, PhD, Yasuo Ikeda, MD, Masahiro Kizaki, MD

Blood (2004) 104 (11): 765.

https://doi.org/10.1182/blood.V104.11.765.765

Published: 2004

NARROW

The Clinical Impact of Modified Barthel Index in Elderly Patients over 60 Years with Diffuse Large B-Cell Lymphoma

Comparison of the Clinical Outcomes of Nilotinib and Dasatinib Therapies in Newly Diagnosed Patients in the Chronic Phase of Chronic Myeloid Leukemia: A Retrospective Analysis

Serum Reactive Oxygen Metabolite Levels Are Associated with Poor Prognosis in Patients with Diffuse Large B-Cell Lymphoma

Prognostic Significance of Neuron-Specific Enolase in Patients with Malignant Lymphoma

A Prospective Observational Study Evaluating Sarcopenia By Using the Bioelectrical Impedance Analysis in Elderly Patients with Hematologic Malignancies

Phase II Clinical Trial of Personalized-VCD-VTD Sequential Therapy Using VES-13 for Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma

Successful MPB Therapy Followed By Bortezomib Maintenance for Non-Transplant Eligible Patients with Newly Diagnosed Multiple Myeloma: Japanese Phase 2 Study - Broad-J Study

Oxidative Stress Is Associated with Poor Prognosis in Patients with Malignant Lymphoma

Once-Weekly Subcutaneous Bortezomib Plus Oral Cyclophosphamide and Dexamethasone Therapy For Relapsed Or Refractory Multiple Myeloma

Myeloperoxidase (MPO) Is a Key Regulator of Oxidative Stress-Mediated Apoptosis in Myeloid Leukemic Cells.

Green Tea Component, Catechin, Induces Apoptosis of Myeloid Leukemic Cells Via Myeloperoxidase (MPO)-Dependent Highly Reactive Oxygen Species (ROS) Production.

Shikonin Induces Apoptosis by Inhibiting Phosphorylation of IGF-1 Receptor in Myeloma Cells.

A Green Tea Component, Catechin, Induces Apoptosis of Human Myeloma Cells and Markedly Enhances Arsenic Trioxide-Induced Cytotoxicity Via Production of Reactive Oxygen Species (ROS).

1′-Acetoxychavicol Acetate (ACA) Is a Novel NF-κB Inhibitor with Significant Activity Against Multiple Myeloma in Vitro and in Vivo .

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only